SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-016076
Filing Date
2019-10-29
Accepted
2019-10-29 12:30:51
Documents
17
Period of Report
2019-10-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 36493
2 ex99-1.htm EX-99.1 14952
3 ex99-1_001.jpg GRAPHIC 524126
4 ex99-1_002.jpg GRAPHIC 716075
5 ex99-1_003.jpg GRAPHIC 2547168
6 ex99-1_004.jpg GRAPHIC 354697
7 ex99-1_005.jpg GRAPHIC 565050
8 ex99-1_006.jpg GRAPHIC 401937
9 ex99-1_007.jpg GRAPHIC 339265
10 ex99-1_008.jpg GRAPHIC 631946
11 ex99-1_009.jpg GRAPHIC 543417
12 ex99-1_010.jpg GRAPHIC 504134
13 ex99-1_011.jpg GRAPHIC 483279
14 ex99-1_012.jpg GRAPHIC 410995
15 ex99-1_013.jpg GRAPHIC 613968
16 ex99-1_014.jpg GRAPHIC 334932
17 ex99-1_015.jpg GRAPHIC 935709
  Complete submission text file 0001493152-19-016076.txt   13628824
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 191175509
SIC: 2834 Pharmaceutical Preparations